Login

The article explores how technology is disrupting home insurance, featuring insights from Lemonade Inc. CEO. 00:10:00

Share On Facebook Share On Twitter

John has served as LivePerson's CEO since January 2024.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Bajaj Electricals' Summer Campaigns: 'Fan Nahi, Fantastic' and Air Coolers Strategy Amid Post-Pandemic Recovery| ANUJ PODDAR,Managing Director & CEO,Bajaj Electricals Ltd.
00:10:00
EQT's 2021 Achievements and Future Goals: Christian Sinding's Address | Christian Sinding, CEO, EQT.
00:00:00
Mitigating COVID-19 Gender Disparities - Dr. Hannah Nordhues, an Assistant Professor of Medicine in General and Internal Medicine at Mayo Clinic
00:10:00
Gary Kaminsky: Championing Transparency at Capital Wealth Planning
00:10:00
The March to Marxism: Addressing Cancel Culture and Law Enforcement Challenges|Joshua David Hawley
00:10:00
Enhancing Customer Experience Through Digitalization and Integrated Platforms | Márcia Sandra Vieira, CEO, Companhia Energetica do Ceara.
00:10:00
Standing Out to Clients: Insights from Morgan Stanley's CMO and Facebook's VP of Global Marketing Solutions
00:10:00
NCR Atleos, now an independent company transforming the ATM industry, features CEO Tim Oliver in an interview.|Michael D. Hayford Retiring as NCR Chief Executive Officer
00:10:00
Innovative Solutions for Mining Challenges: Transforming Safety and Efficiency
00:10:00
Developing Bardoc Gold: Tier One Gold Project with Strong Margins
00:10:00
Inflection Resources Targets Tier One Copper-Gold Deposits in New South Wales
00:10:00
venture capital who has adapted to a new career path, depending on the direction|Amy Saper,Partner,Accel

© 2026 Nehu